Pediatric Vaccine Global Market Report 2022 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies), By Application (Infectious Disease, Allergy, Cancer) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 150 | Published : February 2022 | SKU CODE : 7640 | Delivery Time: 2-3 business days | Format :


The pediatric vaccines market consists of sales of pediatric vaccines and its related services used to provide immunity to infants and children for specific diseases. The pediatric vaccine is a preparation of killed microorganisms, living attenuated organisms, or living fully virulent organisms that are administered to stimulate the production of antibodies and provide immunity against one or several diseases among children. Pediatric vaccines are used in childhood immunization schedules to enhance a child’s immunity or prevent diseases such as diphtheria, tetanus, pertussis, influenza, Hepatitis B, polio, and many other infectious and non-infectious diseases.

The main types of pediatric vaccines are monovalent and multivalent. A monovalent vaccine is made up of only one antigen strain. The technology used include live attenuated, inactivated, toxoid, conjugate and other technologies to provide immunity from infectious disease, allergy and cancer.

The global pediatric vaccine market size is expected to grow from $31.44 billion in 2021 to $36.64 billion in 2022 at a compound annual growth rate (CAGR) of 16.5%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The pediatric vaccine market is expected to reach $57.51 billion in 2026 at a CAGR of 11.9%.

The rising prevalence of chronic diseases such as tuberculosis, diphtheria, and pneumonia in the age group of 15 years and below will contribute to the growth of the pediatric vaccines market. The risk of severe disease outcomes and complications of infectious diseases are increasing in children and adolescents with chronic conditions. According to the World Health Organization, chronic disease prevalence irose by 57% in the year 2020. The increased prevalence of chronic diseases among children rises the demand for immunization from chronic diseases, hence, driving the pediatric vaccines market’s growth.

Vaccine refusal by parents for their children is a prevailing tradition in many countries. Among the reasons for withholding children for vaccination are lack of knowledge, religious and philosophical objections, exaggerated concerns regarding vaccine safety, and others. According to a nationwide survey found that over half (51%) of pediatric services in the United States have the policy to dismiss families that refuse childhood vaccines. 37% of pediatricians themselves said they often dismissed families for refusing vaccines, and 6% said they would dismiss a family for choosing to reach out to crucial early vaccines. Governments are imposing laws and organizing awareness programs to overcome parent’s and family’s resistance to the child’s vaccine, but are unable to impose any strict rules against parents’ refusal for children’s immunization, which may hinder the pediatric vaccines market’s growth.

The demand for novel vaccines is steadily growing to deliver improved immunization against challenging infectious diseases (e.g. tuberculosis, HIV/ AIDS) and non-communicable chronic diseases such as cancer and neurodegenerative diseases. Novel approaches to vaccine development include structural immunogenic design, gene-based vaccine platforms, and effective adjuvant recombinant antigen formulations. To meet the increasing demand for novel vaccines, there is a continuous quest for pediatric vaccine manufacturers and developers for innovation of vaccine design and manufacturing technologies. For instance, in January 2020, Hilleman laboratories, global research, and development organization, has announced their plans to develop a novel vaccine against Group B Streptococcus, a major cause for neonatal infections in women, in the area of maternal and child health.

Major players in the pediatric vaccines market are GlaxoSmithKline plc, Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Indian Immunologicals Limited, AstraZeneca plc, CSL Limited, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd., Panacea Biotec Ltd., Zydus Cadila, BIO-MED, Squibb, Novartis, Abbott Laboratries, Eli Lillyand Company, F. Hoffmann- La Roche Ltd., Novo Nordisk A/S, VF Corporation, Sinovac Biotech Ltd., Bristol- Myers, Sun Pharmaceutical Industries Ltd, Sellas and Takeda Pharmaceutical Company Limited, Daiichi Sankyo, Bristol- Myers and Sinovac Biotec Ltd.

North America was the largest region in the pediatric vaccines market in 2021. The Middle East is expected to be the fargest growing region in the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pediatric vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The global pediatric vaccine market is segmented -

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies

3) By Application: Infectious Disease, Allergy, Cancer

    Table Of Contents

    1. Executive Summary

    2. Pediatric Vaccines Market Characteristics

    3. Pediatric Vaccines Market Trends And Strategies

    4. Impact Of COVID-19 On Pediatric Vaccines

    5. Pediatric Vaccines Market Size And Growth

    5.1. Global Pediatric Vaccines Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Pediatric Vaccines Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Pediatric Vaccines Market Segmentation

    6.1. Global Pediatric Vaccines Market, Segmentation  By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Monovalent

    Multivalent

    6.2. Global Pediatric Vaccines Market, Segmentation  By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

     Live Attenuated

    Inactivated

    Toxoid

    Conjugate

    Other Technologies

    6.3. Global Pediatric Vaccines Market, Segmentation  By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Infectious Disease

    Allergy

    Cancer

    7. Pediatric Vaccines Market Regional And Country Analysis

    7.1. Global Pediatric Vaccines Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global Pediatric Vaccines Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific Pediatric Vaccines Market  

    8.1. Asia-Pacific Pediatric Vaccines Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China Pediatric Vaccines Market  

    9.1. China Pediatric Vaccines Market Overview  

    9.2. China Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India Pediatric Vaccines Market  

    10.1. India Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan Pediatric Vaccines Market  

    11.1. Japan Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia Pediatric Vaccines Market  

    12.1. Australia Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia Pediatric Vaccines Market  

    13.1. Indonesia Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea Pediatric Vaccines Market  

    14.1. South Korea Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe Pediatric Vaccines Market  

    15.1. Western Europe Pediatric Vaccines Market Overview

    15.2. Western Europe Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK Pediatric Vaccines Market  

    16.1. UK Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany Pediatric Vaccines Market  

    17.1. Germany Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France Pediatric Vaccines Market  

    18.3. France Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe Pediatric Vaccines Market  

    19.1. Eastern Europe Pediatric Vaccines Market Overview

    19.2. Eastern Europe Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia Pediatric Vaccines Market  

    20.1. Russia Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America Pediatric Vaccines Market  

    21.1. North America Pediatric Vaccines Market Overview

    21.2. North America Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA Pediatric Vaccines Market  

    22.1. USA Pediatric Vaccines Market Overview

    22.2. USA Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America Pediatric Vaccines Market  

    23.1. South America Pediatric Vaccines Market Overview

    23.2. South America Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil Pediatric Vaccines Market  

    24.1. Brazil Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East Pediatric Vaccines Market  

    25.1. Middle East Pediatric Vaccines Market Overview

    25.2. Middle East Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa Pediatric Vaccines Market  

    26.1. Africa Pediatric Vaccines Market Overview

    26.2. Africa Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. Pediatric Vaccines Market Competitive Landscape And Company Profiles

    27.1. Pediatric Vaccines Market Competitive Landscape

    27.2. Pediatric Vaccines Market Company Profiles

    27.2.1. GlaxoSmithKline plc

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Pfizer Inc.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Sanofi S.A.

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Merck & Co., Inc.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Indian Immunologicals Limited

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Pediatric Vaccines Pipeline Analysis

    29. Key Mergers And Acquisitions In The Pediatric Vaccines Market

    30. Pediatric Vaccines Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Research Inquiries

    31.4. The Business Research Company

    31.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global Pediatric Vaccines Market, Segmentation  By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4: Global Pediatric Vaccines Market, Segmentation  By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5: Global Pediatric Vaccines Market, Segmentation  By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6: Global Pediatric Vaccines Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Pediatric Vaccines Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Asia-Pacific, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: China, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: India, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: Japan, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12: Australia, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13: Indonesia, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14: South Korea, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15: Western Europe, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16: UK, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17: Germany, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18: France, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19: Eastern Europe, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20: Russia, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21: North America, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22: USA, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23: South America, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24: Brazil, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25: Middle East, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26: Africa, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27: GlaxoSmithKline plc Financial Performance
  • Table 28: Pfizer Inc. Financial Performance
  • Table 29: Sanofi S.A. Financial Performance
  • Table 30: Merck & Co., Inc. Financial Performance
  • Table 31: Indian Immunologicals Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3: Global Pediatric Vaccines Market, Segmentation  By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4: Global Pediatric Vaccines Market, Segmentation  By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5: Global Pediatric Vaccines Market, Segmentation  By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6: Global Pediatric Vaccines Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Pediatric Vaccines Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Asia-Pacific, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: China, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: India, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: Japan, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12: Australia, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13: Indonesia, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14: South Korea, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15: Western Europe, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16: UK, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17: Germany, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18: France, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19: Eastern Europe, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20: Russia, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21: North America, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22: USA, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23: South America, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24: Brazil, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25: Middle East, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26: Africa, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27: GlaxoSmithKline plc Financial Performance
  • Figure 28: Pfizer Inc. Financial Performance
  • Figure 29: Sanofi S.A. Financial Performance
  • Figure 30: Merck & Co., Inc. Financial Performance
  • Figure 31: Indian Immunologicals Limited Financial Performance
Global Anti-Infective Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell and Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pharmaceutical Drugs And Biologics Logistics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Therapeutic Proteins Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Ambulatory IV Infusion Pumps Global Market Report 2022 – By Type (Disposable Infusion Pumps, Chemotherapy Infusion Pump), By End-User (Hospitals, Home Healthcare, Other End Users), By Application (Chemotherapy/Oncology, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Other Applications) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Anesthesia Disposables Global Market Report 2022 – By Product (Anesthesia Breathing Circuits, Endotracheal Tubes, Anesthesia Gas Masks, Laryngeal Mask Airway), By End Users (Hospitals, Clinics, Home Care Settings, Other End users), By Patient Group (Neonatal, Adult, Pediatric) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Cell Therapy Global Market Report 2022 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous Therapies), By Application (Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines), By Route of Administration (Intramuscular (IM), Subcutaneous (SC), Oral, Others), By Valance (Monovalent, Multivalent), By Distribution Channel (Institutional Sale, Hospital Pharmacies, Retail Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Biologics Global Market Report 2022 – By Type (Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Bi-Specific MAbS Global Market Report 2022 – By Type (Catumaxomab (Removab), Blinatumomab, Duligotumab, SAR 156597), By Product Type (In Vivo, In Vitro), By Indication (Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, Microbial Diseases), By End Use (Hospitals, Research Institutes) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Cancer Vaccines Global Market Report 2022 – By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), By Cancer Type (Prostate, Cervical, Colorectal, Throat), By End-User (Cancer Treatment Centers, Research Institutes) – Market Size, Trends, And Global Forecast 2022-2026
View Report
DTP Vaccines Global Market Report 2022 – By Product Type (DTaP, TD, Tdap), By Disease (Diphtheria, Pertussis, Tetanus), By End User (Hospitals, Clinics, Vaccination Centers) – Market Size, Trends, And Global Forecast 2022-2026
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)